MDS Congress 2025 Session Evaluation

MDS Congress 2025 Session 1102 Evaluation Form
Therapeutic Plenary Session 1102

Pharmacological Management of Parkinson’s Disease

October 5, 2025

10:30 - 12:00
Learning Objectives:

1. Select initial pharmacological management of motor symptoms based on evidence of its impact on long-term outcomes
2. Recognize and manage autonomic and cognitive dysfunction in Parkinson’s disease
3. Discuss pharmacological options for motor and non-motor fluctuations in Parkinson’s disease
Session Evaluation
The session met its learning objectives

Strongly agreeAgreeDisagreeStrongly disagree
The content is relevant to my professional and / or scientific interests.

Strongly agreeAgreeDisagreeStrongly disagree
The quality of the education process (method of presentation and information provided) was satisfactory and appropriate.

Strongly agreeAgreeDisagreeStrongly disagree
The information provided will enhance my care of patients with Movement Disorders and / or advance my scientific understanding of Movement Disorders.

Strongly agreeAgreeDisagreeStrongly disagree
The overall session organization was satisfactory and appropriate.

Strongly agreeAgreeDisagreeStrongly disagree
I would recommend this session to a colleague.

Strongly agreeAgreeDisagreeStrongly disagree
Faculty Assessment
Shen-Yang Lim, Malaysia
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
Melissa Armstrong, USA
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
Regina Katzenschlager, Austria
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
How would you improve this activity?
Please provide any additional comments
The following category best describes your current major professional activity (choose one):

Patient managementBasic Science researchClinical ResearchTeachingResident/PhD StudentUndergraduate StudentOther
My country:
Should be Empty:

MDS Congress 2025 Session 1102 Evaluation Form

Therapeutic Plenary Session 1102

Pharmacological Management of Parkinson’s Disease